Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Human Immunology|January 23, 2024
Activating KIR/HLA-I combinations as a risk factor of adult B-ALLHossein Halimi, Sara Mirzazadeh, Kurosh Kalantar, et al.
BMC Immunology|June 29, 2024
The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to severe COVID-19 in the Iranian populationNarges Karami, Shaghik Barani, Mona Fani, et al.
Iranian Journal of Allergy, Asthma, and Immunology|June 15, 2020
Pro-inflammatory Effects of Influenza Type A Virus PB1-F2 Protein-derived Peptide in Lipopolysaccharide-treated MacrophagesKurosh Kalantar, Zahra Farzaneh, Nasser Gholijani, et al.
Frontiers in Aging|March 20, 2024
Alterations in metabolic pathways: a bridge between aging and weaker innate immune responseZahra Saleh, Sara Mirzazadeh, Fatemeh Mirzaei, et al.
Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit|December 23, 2020
Identification of immunoreactive proteins in secretions of Leishmania infantum promastigotes: an immunoproteomic approachSajad Rashidi, Paul Nguewa, Zahra Mojtahedi, et al.
Clinical and Experimental Hepatology|September 11, 2019
Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejectionKeivan Shams, Kurosh Kalantar, Mohammad Hossein Karimi, et al.
Journal of Cellular Physiology|February 21, 2019
Influence of forkhead box protein 3 polymorphisms (rs2232365, rs3761548) with the outcome of pregnancy: A meta-analysisSaeed Hosseini Teshnizi, Mohammad Ali-Hassanzadeh, Behrouz Gharesi-Fard, et al.
Human Vaccines & Immunotherapeutics|June 12, 2026
Nanomaterial-based vaccines: An advanced approach against rotavirus: A review articleAhmadreza Soroush Fard, Kurosh Kalantar, Ali Teimoori, et al.
Pathogens and Disease|February 14, 2020
Chitin binding protein as a possible RNA binding protein in Leishmania parasitesSajad Rashidi, Kurosh Kalantar, Celia Fernandez-Rubio, et al.
Current Molecular Medicine|May 23, 2023
Targeting TRIM29 As a Negative Regulator of CAR-NK Cell Effector Function to Improve Antitumor Efficacy of these Cells: A PerspectiveZahra Saleh, Maryam Noroozi, Mahsa Eshkevar Vakili, et al.
Pageof 6